Boston Partners - RECRO PHARMA INC ownership

RECRO PHARMA INC's ticker is REPH and the CUSIP is 75629F109. A total of 56 filers reported holding RECRO PHARMA INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Boston Partners ownership history of RECRO PHARMA INC
ValueSharesWeighting
Q3 2022$150,000
-5.1%
92,246
-53.6%
0.00%
Q2 2022$158,000
-65.9%
198,712
-22.7%
0.00%
-100.0%
Q1 2022$463,000
+5.2%
257,0900.0%0.00%0.0%
Q4 2021$440,000
+10.0%
257,090
+32.6%
0.00%0.0%
Q3 2021$400,000
+19.0%
193,944
+33.4%
0.00%
Q2 2021$336,000
+17.5%
145,374
+41.7%
0.00%
Q1 2021$286,000
-2.1%
102,6230.0%0.00%
Q4 2020$292,000
-63.3%
102,623
+5.3%
0.00%
-100.0%
Q1 2020$796,000
-83.4%
97,455
-62.8%
0.00%
-33.3%
Q4 2019$4,800,000
+212.3%
261,904
+88.8%
0.00%
+50.0%
Q3 2019$1,537,000138,7520.00%
Other shareholders
RECRO PHARMA INC shareholders Q4 2021
NameSharesValueWeighting ↓
Samjo Capital LLC 8,039,100$3,770,3381.48%
First Light Asset Management, LLC 19,676,396$9,228,2300.88%
AWM Investment Company, Inc. 10,266,144$4,814,8220.71%
Caligan Partners LP 1,689,768$794,1910.36%
HighMark Wealth Management LLC 484,985$227,4580.19%
Nantahala Capital Management 1,250,000$586,2500.05%
Clear Harbor Asset Management, LLC 938,847$440,3190.05%
DRIEHAUS CAPITAL MANAGEMENT LLC 4,249,229$1,992,8880.03%
TITLEIST ASSET MANAGEMENT, LLC 210,148$98,5590.02%
ROYCE & ASSOCIATES LP 3,285,082$1,540,7030.02%
View complete list of RECRO PHARMA INC shareholders